Robert M Plenge - Net Worth and Insider Trading
Robert M Plenge Net Worth
The estimated net worth of Robert M Plenge is at least $343,067 dollars as of 2025-05-04. Robert M Plenge is the EVP, Chief Research Officer of Bristol-Myers Squibb Co and owns about 6,784 shares of Bristol-Myers Squibb Co (BMY) stock worth over $343,067. Details can be seen in Robert M Plenge's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert M Plenge has not made any transactions after 2023-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert M Plenge
Robert M Plenge Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert M Plenge owns 2 companies in total, including Translate Bio Inc (TBIO) , and Bristol-Myers Squibb Co (BMY) .
Click here to see the complete history of Robert M Plenge’s form 4 insider trades.
Insider Ownership Summary of Robert M Plenge
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TBIO | Translate Bio Inc | 2020-06-16 | director |
| BMY | Bristol-Myers Squibb Co | 2023-08-03 | EVP & Chief Research Officer |
Robert M Plenge Latest Holdings Summary
Robert M Plenge currently owns a total of 1 stock. Robert M Plenge owns 6,784 shares of Bristol-Myers Squibb Co (BMY) as of August 3, 2023, with a value of $343,067.
Latest Holdings of Robert M Plenge
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2023-08-03 | 6,784 | 50.57 | 343,067 |
Holding Weightings of Robert M Plenge
Robert M Plenge Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert M Plenge has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bristol-Myers Squibb Co is the sale of 732 shares on August 3, 2023, which brought Robert M Plenge around $44,755.
Insider Trading History of Robert M Plenge
- 1
Robert M Plenge Trading Performance
Robert M Plenge Ownership Network
Ownership Network List of Robert M Plenge
Ownership Network Relation of Robert M Plenge
Robert M Plenge Owned Company Details
What does Translate Bio Inc do?
Who are the key executives at Translate Bio Inc?
Robert M Plenge is the director of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Shire Human Genetic Therapies, Inc. .
Translate Bio Inc (TBIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Translate Bio Inc Insider Transactions
Robert M Plenge Mailing Address
Above is the net worth, insider trading, and ownership report for Robert M Plenge. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert M Plenge's mailing address is: Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
